Market Overview

Mid-Day Market Update: Dow Falls Over 150 Points; Calithera Biosciences Shares Spike Higher

Related TDW
Mid-Morning Market Update: Markets Open Lower; United Technologies To Buy Rockwell Collins For $30 Billion
Mid-Afternoon Market Update: AMC Entertainment Drops Amid Q2 Warning; Spirit AeroSystems Shares Surge
Tidewater (TDW) Presents At Credit Suisse 19th Annual Financial Services Forum - Slideshow (Seeking Alpha)
Related CHKR
Mid-Afternoon Market Update: Ferroglobe Rises After Q1 Results; Great Basin Scientific Shares Drop
Mid-Afternoon Market Update: Dow Falls 50 Points; Moneygram International Shares Surge

Midway through trading Monday, the Dow traded down 0.80 percent to 19,933.85 while the NASDAQ declined 1.06 percent to 5,600.80. The S&P also fell, dropping 0.87 percent to 2,274.72.

Leading and Lagging Sectors

Non-cyclical consumer goods & services shares slipped by just 0.1 percent in trading on Monday.

In trading on Monday, energy shares tumbled by 1.8 percent. Meanwhile, top losers in the sector included Tidewater Inc. (NYSE: TDW), down 12 percent, and Chesapeake Granite Wash Trust (NYSE: CHKR), down 11 percent.

Top Headline

Booz Allen Hamilton Holding Corporation (NYSE: BAH) reported weaker-than-expected earnings for its third quarter.

Booz Allen reported Q3 adjusted earnings of $0.38 per share on revenue of $1.4 billion. Analysts were expecting earnings of $0.40 per share on revenue of $1.37 billion.

Booz Allen also raised its quarterly dividend from $0.15 per share to $0.17 per share.

Equities Trading UP

Calithera Biosciences Inc (NASDAQ: CALA) shares shot up 50 percent to $6.89. Incyte Corporation (NASDAQ: INCY) and Calithera Biosciences reported a global collaboration for the development and commercialization of CB-1158.

Shares of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) got a boost, shooting up 13 percent to $1.84 after the company reported positive top-line data from first-in-human pilot trial of Ocular Bandage Gel in corneal epithelial defects.

CymaBay Therapeutics Inc (NASDAQ: CBAY) shares were also up, gaining 12 percent to $1.87. H.C. Wainwright upgraded CymaBay Therapeutics from Neutral to Buy and raised the price target from $2.50 to $6.00.

Equities Trading DOWN

Ocera Therapeutics Inc (NASDAQ: OCRX) shares dropped 68 percent to $0.650 after the company reported top-line results for Phase 2b study in Hepatic Encephalopathy.

Shares of Regulus Therapeutics Inc (NASDAQ: RGLS) were down around 50 percent to $1.12 after the company received a written communication from the U.S. Food and Drug Administration that the clinical development for the company's RG-101 remains on clinical hold.

Tempur Sealy International Inc (NYSE: TPX) was down, falling around 31 percent to $43.33 following announcement of termination of Mattress Firm (NASDAQ: MFRM) contracts.


In commodity news, oil traded down 0.81 percent to $52.74 while gold traded up 0.65 percent to $1,198.80.

Silver traded up 0.08 percent Monday to $17.15, while copper fell 1.64 percent to $2.65.


European shares were lower today. The eurozone’s STOXX 600 dropped 1.09 percent, the Spanish Ibex Index fell 1.56 percent, while Italy’s FTSE MIB Index declined 2.90 percent. Meanwhile the German DAX slipped 1.16 percent, and the French CAC 40 declined 1.22 percent while U.K. shares fell 0.92 percent.


U.S. consumer spending rose 0.5 percent for December, matching economists’ expectations for a 0.5 percent growth. Personal income increased 0.30 percent last month, versus estimates of 0.40 percent gain.

The pending home sales index rose 1.6 percent to 109 in December. Economists were expecting a 1.1 percent growth.

The Dallas Fed manufacturing business index rose to 22.10 in January, versus a revised reading of 17.70 in the previous month. Economists projected a reading of 15.00.

Posted-In: Earnings News Eurozone Commodities Global Intraday Update Markets Movers


Related Articles (BAH + CALA)

View Comments and Join the Discussion!